Eye-Link Foundation
  • OUR STORY
  • Resources
  • Contact
  • News
  • OUR STORY
  • Resources
  • Contact
  • News

Gene Therapy for Retinitis Pigmentosa and Other Conditions

11/29/2021

0 Comments

 

HOW YOUR OWN DNA COULD SOMEDAY SAVE YOUR VISION

Imagine living with a genetic disease that could cause blindness in your 40s—and your doctor tells you there are no treatment options. It's for patients like these that Johnson & Johnson is harnessing cutting-edge technology in the hope of finding real solutions.

By Hallie Levine    October 11, 2021

It can be devastating to watch someone slowly lose their vision.

Just ask James List, M.D., Ph.D., Global Therapeutic Area Head of Cardiovascular, Metabolism and Retina at Janssen Research & Development, part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Before he joined the company in 2014, the Harvard endocrinologist spent his days counseling patients with diabetes. “Many people don’t realize that diabetes can cause irreversible damage to multiple organs, including the eyes,” he says.

READ MORE
0 Comments



Leave a Reply.

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    February 2023
    March 2022
    February 2022
    November 2021
    October 2021
    November 2020
    January 2018
    September 2017

    Categories

    All

    RSS Feed

CONTACT US

email: eyelinkfoundation@gmail.com
phone: 763-561-6967

BOARD OF DIRECTORS

Jim Justesen, Chairman
T. R. Dallmann, Vice Chairman
Paul Mount, Treasurer
Lori Thompson, Secretary

© 2020-2021 Eye-Link Foundation. All Rights Reserved.